Artiva Biotherapeutics (ARTV) Other Gross PP&E Adjustments: 2023-2025
Historic Other Gross PP&E Adjustments for Artiva Biotherapeutics (ARTV) over the last 2 years, with Sep 2025 value amounting to $3.5 million.
- Artiva Biotherapeutics' Other Gross PP&E Adjustments rose 260.76% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year change of. This contributed to the annual value of -$1.5 million for FY2024, which is 69.49% up from last year.
- Per Artiva Biotherapeutics' latest filing, its Other Gross PP&E Adjustments stood at $3.5 million for Q3 2025, which was up 163.41% from $1.3 million recorded in Q2 2025.
- Artiva Biotherapeutics' 5-year Other Gross PP&E Adjustments high stood at $3.5 million for Q3 2025, and its period low was -$4.9 million during Q4 2023.
- For the 3-year period, Artiva Biotherapeutics' Other Gross PP&E Adjustments averaged around -$963,000, with its median value being -$1.5 million (2024).
- Data for Artiva Biotherapeutics' Other Gross PP&E Adjustments shows a peak YoY skyrocketed of 260.76% (in 2025) over the last 5 years.
- Over the past 3 years, Artiva Biotherapeutics' Other Gross PP&E Adjustments (Quarterly) stood at -$4.9 million in 2023, then skyrocketed by 69.49% to -$1.5 million in 2024, then skyrocketed by 260.76% to $3.5 million in 2025.
- Its Other Gross PP&E Adjustments was $3.5 million in Q3 2025, compared to $1.3 million in Q2 2025 and $109,000 in Q1 2025.